SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-17-000021
Filing Date
2017-02-28
Accepted
2017-02-28 07:37:26
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lgnd-20161231x10k.htm 10-K 2636133
2 EXHIBIT 23.1 lgnd_123116xexhibit231.htm EX-23.1 5023
3 EXHIBIT 23.2 lgnd_123116xexhibit232.htm EX-23.2 2238
4 EXHIBIT 31.1 lgnd_123116xexhibit311.htm EX-31.1 19567
5 EXHIBIT 31.2 lgnd_123116xexhibit312.htm EX-31.2 20532
6 EXHIBIT 32.1 lgnd_123116xexhibit321.htm EX-32.1 15749
13 stockperformancegraphv3.jpg GRAPHIC 131829
  Complete submission text file 0000886163-17-000021.txt   11591647

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lgnd-20151231.xml EX-101.INS 2417185
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20151231.xsd EX-101.SCH 68009
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20151231_cal.xml EX-101.CAL 140548
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20151231_def.xml EX-101.DEF 382610
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20151231_lab.xml EX-101.LAB 1067403
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20151231_pre.xml EX-101.PRE 592927
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 17644718
SIC: 2834 Pharmaceutical Preparations